Featured Post

Latest Gold News

Fed doves supporting gold Stronger rand crushing South African miners Economic power could shift further East with Hong Kong gold exch...

Tuesday, January 10, 2012

Pfizer (PFE) (MMI) (PRX) (ANGO) (APH) (ART) Ratings Reiterated

Pfizer Inc. (NYSE: PFE), Motorola Mobility (NYSE: MMI), Par Pharmaceutical Companies Incorporated (NYSE: PRX), AngioDynamics (NASDAQ: ANGO), Amphenol Co. (NYSE: APH) and Artio Global Investors Inc. (NYSE: ART) had ratings on them reiterated by analysts.

Goldman Sachs (NYSE:GS) reiterated its "Conviction Buy" rating on Pfizer Inc. (PFE).

Canaccord Genuity reiterated its "Hold" rating on Motorola Mobility (MMI).

UBS AG (NYSE:UBS) reiterated its "Buy" rating on Par Pharmaceutical Companies Incorporated (PRX).

Zacks Investment Research reiterated its "Neutral" rating on AngioDynamics (ANGO). They have a price target of $14.00 on the company.

Goldman Sachs reiterated its "Neutral" rating on Amphenol Co. (APH).

Goldman Sachs reiterated its "Neutral" rating on Artio Global Investors Inc. (ART).

No comments: